About Optimal Tracers
Optimal Tracers is a Healthcare company based in Sacramento (United States) founded in 2013, and was acquired by Telix Pharma in November 2022. CRO focused on clinical research and tracer development services. Its chief executive, as recorded, is Ruth Tesar. Optimal Tracers offers products and services including Radiotracers and PET Tracers. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Ophthalmology. Its competitors include Lexitas, EyeCRO and Humonix Biosciences.
Company details
Optimal Tracers offers Radiotracers, PET Tracers while focusing on providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and ophthalmology. CRO focused on clinical research and tracer development services. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
- Headquarters Sacramento, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website optimaltracers.org
- Social LinkedIn Facebook
- Acquired by Telix Pharma (Nov 2022)
- Investors
- Acquired byTelix Pharma
(Nov 2022)
Products & Services of Optimal Tracers
Optimal Tracers offers a comprehensive portfolio of products and services, including Radiotracers and PET Tracers.
Custom radiotracers for clinical and pre-clinical applications.
Radiolabeled tracers for PET imaging and quality control.
Investors in Optimal Tracers
Optimal Tracers has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Telix Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy. | 2015 | telixpharma.com | Melbourne, Australia |
Investor details for Optimal Tracers
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Optimal Tracers
3 people are tracked at Optimal Tracers (1 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Ruth Tesar | CEO | Leadership |
Ephraim Obot | Site Manager & Senior PET Radiochemist | Team |
Ljan Ordiz | Radiochemistry Technician & Quality Manager | Team |
Complete people profiles for Optimal Tracers
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Optimal Tracers
2 dated milestones of Optimal Tracers across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Optimal Tracers is founded.
- Exit Acquired by Telix Pharma.
Competitors of Optimal Tracers
Optimal Tracers has 3 listed competitors in our database. They include Lexitas, EyeCRO and Humonix Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lexitas.com | 2011 | Durham, United States | 106 | Clinical trials and medical strategies for ophthalmology products are provided. | ||
| eyecro.com | 2011 | Oklahoma, United States | Provider of in vivo and in vitro models for ophthalmic research | |||
| humonixbio.com | 2014 | Albany, United States | CRO focused on ophthalmic drugs development services |
Detailed competitors of Optimal Tracers
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Optimal Tracers (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optimal Tracers
Complete news archive for Optimal Tracers
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optimal Tracers
Optimal Tracers was founded in 2013.
Optimal Tracers is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Ruth Tesar is the CEO of Optimal Tracers, as recorded in our data.
Optimal Tracers offers Radiotracers, PET Tracers while focusing on providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and ophthalmology. CRO focused on clinical research and tracer development services. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
Optimal Tracers's top competitors include Lexitas, Humonix Biosciences and EyeCRO.
Optimal Tracers offers Radiotracers and PET Tracers.
Optimal Tracers has 1 investor. Key investors include Telix Pharmaceuticals.
Yes. Optimal Tracers was acquired by Telix Pharma in November 2022.